Related Experiment Video

Updated: Jul 17, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

[Clinical examinations based on nucleic acids of hepatitis viruses]

Yasuhito Tanaka1, Masashi Mizokami

  • 1Department of Clinical Molecular Informative Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|January 24, 2007
PubMed

Insights

Hepatitis B (HBV) and Hepatitis C (HCV) cause chronic liver disease. Understanding their genotypes is crucial for early diagnosis, effective treatment, and preventing liver cancer.

Area of Science:

  • Hepatology
  • Virology
  • Genetics

Context:

  • Viral hepatitis, particularly hepatitis B (HBV) and hepatitis C (HCV), is a leading cause of acute and chronic liver inflammation.
  • HBV and HCV infections are significant risk factors for developing chronic liver disease and hepatocellular carcinoma.
  • Early detection, prevention strategies, and viral eradication are critical for managing HBV and HCV.

Purpose:

  • To review diagnostic methods based on viral nucleic acids for HBV and HCV genotypes.
  • To correlate clinical manifestations with specific HBV and HCV genotypes.
  • To provide an overview of the impact of different HBV and HCV genotypes on disease progression and treatment response.

Summary:

  • Eight HBV genotypes (A-H) and at least six HCV genotypes exist, with distinct geographical distributions.
  • HBV and HCV genotypes influence liver disease severity and the effectiveness of antiviral therapies.
  • Current interferon-based therapy can eradicate HCV, with treatment success dependent on genotype and viral load.

Impact:

  • Highlights the importance of genotype identification for personalized treatment strategies in viral hepatitis.
  • Emphasizes the need for early diagnosis and prevention to reduce the burden of chronic liver disease and liver cancer.
  • Informs clinical practice and future research directions in the management of HBV and HCV infections.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...